Richard K Severson

Author PubWeight™ 119.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004 6.43
2 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006 4.13
3 Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008 2.49
4 Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005 2.27
5 Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004 2.19
6 Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2006 2.15
7 Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 2006 2.06
8 Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 2006 2.02
9 Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis 2007 1.94
10 Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology 2005 1.89
11 Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005 1.87
12 Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005 1.86
13 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
14 Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 2002 1.82
15 Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites. J Expo Anal Environ Epidemiol 2004 1.76
16 The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. J Allergy Clin Immunol 2012 1.76
17 Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005 1.65
18 Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007 1.63
19 Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med 2008 1.61
20 GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 2011 1.58
21 Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 2010 1.56
22 Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 2005 1.55
23 Osteosarcoma as a second malignant neoplasm. Radiother Oncol 2002 1.54
24 Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One 2009 1.52
25 Ethnic differences in survival among women with ovarian carcinoma. Cancer 2002 1.40
26 Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006 1.38
27 Diagnostic X-rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype. Cancer Epidemiol Biomarkers Prev 2002 1.38
28 Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005 1.36
29 Cancer among Arab Americans in the metropolitan Detroit area. Ethn Dis 2004 1.35
30 Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004 1.32
31 Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood 2008 1.26
32 Residential herbicide use and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2005 1.24
33 Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 2005 1.20
34 Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. Am J Epidemiol 2007 1.20
35 Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 2009 1.17
36 Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007 1.17
37 Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005 1.16
38 Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 2006 1.16
39 Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer 2010 1.12
40 Violent victimization of women and men: physical and psychiatric symptoms. J Am Board Fam Pract 2003 1.11
41 Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med 2009 1.10
42 A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect 2011 1.10
43 A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2008 1.08
44 Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 2002 1.07
45 Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006 1.05
46 Breast cancer screening barriers and mammography completion in older minority women. Breast Cancer Res Treat 2005 1.04
47 Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 2007 1.04
48 Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006 1.03
49 Exploring physician and staff perceptions of the learning environment in ambulatory residency clinics. Fam Med 2006 1.01
50 Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study. Environ Health Perspect 2015 1.00
51 Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 2002 0.99
52 Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol 2011 0.98
53 Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 2006 0.97
54 Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol 2003 0.96
55 Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust. Environ Sci Technol 2013 0.96
56 Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol 2002 0.94
57 Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan. Cancer Causes Control 2005 0.94
58 Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med 2009 0.93
59 Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer 2005 0.93
60 Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 2008 0.92
61 Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol 2010 0.91
62 Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer 2008 0.90
63 Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control 2009 0.90
64 Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol 2010 0.89
65 PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood 2012 0.89
66 Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2010 0.88
67 Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev 2008 0.88
68 Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer 2010 0.87
69 Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr Cancer 2012 0.86
70 Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiol 2010 0.86
71 Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 2010 0.85
72 Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol 2006 0.85
73 Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet 2006 0.85
74 Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control 2006 0.85
75 Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 2006 0.84
76 Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer 2006 0.83
77 Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States). Cancer Causes Control 2003 0.83
78 Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004 0.82
79 Cellular telephones and non-Hodgkin lymphoma. Int J Cancer 2006 0.81
80 Pediatric brain tumors in non-Hispanics, Hispanics, African Americans and Asians: differences in survival after diagnosis. Cancer Causes Control 2005 0.81
81 Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials. Pancreas 2010 0.80
82 Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2005 0.80
83 Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. PLoS One 2011 0.80
84 Prostate specific antigen progression after radical prostatectomy in African-American men versus white men. Cancer 2002 0.80
85 Effects of implementation of a team model on physician and staff perceptions of a clinic's organizational and learning environments. Fam Med 2009 0.80
86 Significance of micrometastases on the survival of women with T1 breast cancer. Cancer 2006 0.78
87 Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer 2013 0.78
88 Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. ScientificWorldJournal 2011 0.78
89 Complications from treatment for prostate carcinoma among men in the Detroit area. Cancer 2002 0.78
90 Family history of cancer and non-malignant diseases and risk of childhood acute lymphoblastic leukemia: a Children's Oncology Group Study. Cancer Epidemiol 2011 0.78
91 Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response. Carcinogenesis 2008 0.77
92 Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma. Int J Cancer 2006 0.77
93 Inherited genetic variation and overall survival following follicular lymphoma. Am J Hematol 2012 0.77
94 Quality of life and self-esteem of long-term survivors of invasive and noninvasive cervical cancer. J Womens Health (Larchmt) 2009 0.76
95 APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease. Cholesterol 2011 0.75
96 Household endotoxin levels and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2013 0.75
97 Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr 2008 0.75
98 Hobbies with solvent exposure and risk of non-Hodgkin lymphoma. Cancer Causes Control 2007 0.75